期刊文献+

微小RNA和小干扰RNA在SCA3/MJD的研究进展 被引量:3

Research progress of miRNA and siRNA in spinocerebellar ataxia type 3
下载PDF
导出
摘要 脊髓小脑共济失调3型(SCA3)为多聚谷氨酰胺(PolyQ)病,其致病基因为编码区内含胞嘧啶腺嘌呤鸟嘌呤(CAG)重复序列的ATXN3基因,编码蛋白ataxin3羧基末端含PolyQ肽链,PolyQ扩展突变型ataxin3蛋白可选择性地在中枢神经系统特定区域(小脑、脑干、脊髓等)聚积形成神经元核内包涵体。微小RNA是广泛存在于高等真核细胞中、长度为21~23bp的小分子非编码RNA,与靶基因mRNA的3’端非编码区特异性结合后抑制靶基因的表达。小干扰RNA是RNA干扰技术中的效应分子,其长度为21~23bp,特异性与mRNA的编码序列完全互补结合后,导致mRNA降解和沉默。二者在结构和作用机制存在许多类似之处,可用来进行基因功能分析和疾病发病机制的研究。 Spinocerebellar ataxia type 3 (SCA3) is a type of polyglutamine (polyQ) disease with expansion mutant ATXN3 gene as its causative gene which contains cytosine adenine guanine (CAG) repeat sequence at the coding region of 3 terminal. The polyQ expansion mutant ATXN3 gene encoded polyQ expansion mutant ataxin 3 protein with a polyQ peptide chain at its carboxyl terminal. The polyQ expansion mutant ataxin 3 protein selectively accumulates in specific areas of the central nervous system, such as cerebellum, brainstem, spinal cord, etc, and forms neuronal intranuclear inclusions (NIIs). Researches about micro RNA (miRNA) and small interference RNA (siRNA) are dramatically rapidly increasing. miRNAs are a class of small non coding RNAs that widely exist in higher eukaryotes, with approximately 21-23 bp. They inhibit target gene expression by combining with the 3' untranslated region (3'UTR) of the target gene mRNA. siRNAs are the effect molecules in RNA interference (RNAi) technology, with a length of about 21-23 bp. They induce mRNA degradation and silence on the basis of completely complementary combination with mRNA coding sequence (CDS). miRNA and siRNA have many similarities in both structure and mechanism, and both of them can be used to analyze gene function and to investigate pathogenesis of diseases.
出处 《中国现代神经疾病杂志》 CAS 2013年第8期730-735,共6页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 国家重点基础研究计划(973计划)项目(项目编号:2012CB944601) 国家重点基础研究计划(973计划)项目(项目编号:2012CB517902) 国家重点基础研究计划(973计划)项目(项目编号:2011CB510002) 教育部新世纪优秀人才支持计划项目(项目编号:NCET-10-0836) 国家自然科学基金资助项目(项目编号:81271260) 国家自然科学基金资助项目(项目编号:30971585) 国家自然科学基金资助项目(项目编号:30871354) 国家自然科学基金资助项目(项目编号:30710303061) 国家自然科学基金资助项目(项目编号:30400262)~~
关键词 微RNAS RNA 小分子干扰 MachadoJoseph病 三核苷酸重复 综述 MicroRNAs RNA, small interfering Machado Joseph disease Trinucleotide repeats Review
  • 相关文献

参考文献1

二级参考文献21

  • 1Tang B, Liu C, Shen L, et al. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCAT, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol, 2000, 57(4): 540-544.
  • 2Jiang H, Tang B, Xia K, et al. Spinocerebellar ataxia type 6 in China's Mainland: Molecular and clinical features in four families. J Neurol Sci, 2005, 236(1 -2): 25-29.
  • 3Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet, 1994, 8(3): 221-228.
  • 4Durr A, Stevanin G, Cancel G. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular and neuropathologic features. Ann Neurol, 1996, 39(4): 490-499.
  • 5Tang B S, Zhao G H, Luo W, et al Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet, 2005, 116(3): 222-224.
  • 6Yu S, Thomas H M. The small heat shock proteins and their role in human disease. FEBS J, 2005, 272(11): 2613-2627.
  • 7Kurapati R, Passananti H B, Rose M R, et al Increased hsp22 RNA levels in Drosophila lines genetically selected increased longevity. J Gerontol A Biol Sci Med Sci, 2000, 55(11): B552-559.
  • 8Ross C A, Poirier M A. Protein aggregation and neurodegenerative disease. Nat Med, 2004, 10(Suppl): S 10 -17.
  • 9Kazemi-Esfarjani P, Benzer S. Genetic suppression ofpolyglutamine toxicity in Drosophila. Science, 2000, 287(5459): 1837-1840.
  • 10Warrick J M, Paulson H L, Gray-Board G L. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell, 1998, 93(6): 939-949.

共引文献4

同被引文献32

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部